InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,751.13
(
0.97%
)
US TECH 100
19,557.20
(
1.42%
)
Dow Jones
42,080.37
(
0.30%
)
Brent Oil
77.35
(
-4.44%
)
Bitcoin
62,310.07
(
0.14%
)

Replies to post #263899 on Anavex Life Sciences Corp (AVXL)

Replies to #263899 on Anavex Life Sciences Corp (AVXL)
icon url

JWC3

08/08/20 2:23 AM

#263901 RE: Investor2014 #263899

Totally WRONG!! Get it right. 300,000 possible patients. ANAVEX can sell it at any price. That’s a REVENUE STREAM!

That’s a REVENUE STREAM!

That’s a REVENUE STREAM!

That’s a REVENUE STREAM!

That’s a REVENUE STREAM!
icon url

JWC3

08/08/20 2:34 AM

#263903 RE: Investor2014 #263899

The number of patients possible is greater than 300,000!!!!!!!!

Each patient requires an approval form be filled out and approved. Computers fill out forms! It is like each patient needs an approved perscription form filled out!!!
icon url

Gernee20

08/08/20 12:24 PM

#263971 RE: Investor2014 #263899

They can sell the drug under the SAS program. While miniscule, still revenue, assuming the drug is requested
icon url

vg_future

08/08/20 6:24 PM

#264067 RE: Investor2014 #263899

Investor2014, I disagree. The company raised a small amount and maybe only until some point (date) when Missling got the hint (or maybe unofficial word) of SAS approval. The whole "21 patient/participant thing" from the PR is just a start and is ignoring the potential of the numerous requests that would follow.

-vg_future